News

IMP: How decisions unfold in a zebrafish brain

Researchers observed the entire brains of zebrafish larvae in unprecedented resolution to reconstruct the neural basis...

MedUni Vienna: Von Willebrand factor antigen for assessing the urgency of a liver transplant

The top priority in transplantation medicine is to ensure appropriate allocation of donor organs to patients with the...

amedes expands competence in rare metabolic diseases Cooperation with ARCHIMEDlife

amedes Holding GmbH, a leading provider of interdisciplinary and medical-diagnostic services for patients, physicians...

GMI: Autophagie: Recycling-Zentrum der Pflanzen erforscht Forschungsergebnisse sind auch für Krankheiten wie Alzheimer und Krebs relevant

Pflanzen sind wahre Meister darin, sich an ihre Umwelt anzupassen. Um auf veränderte Umweltbedingungen wie Dürre,...

Valneva: US DoD Exercises Option on IXIARO® Supply Contract Bringing Total Value to $70 Million

Valneva SE (“Valneva” or “the Company”), announced today that the U.S. government Department of Defense (DoD) has...

Petra Heffeter and Walter Berger are MedUni Vienna's Inventors of the Year 2019

At its New Year reception, the Medical University of Vienna honoured Petra Heffeter and Walter Berger from the Institute...

Stadt Wien fördert erste 5G-Anwendungen für die Wienerinnen und Wiener

Digitalisierungsstadtrat Peter Hanke: 5G-Zukunft für die Menschen nutzbar machen

GBA Group Pharma (ABF) Completes Expansion and Scale-Up Project in Anticipation of Brexit

- Vienna facilities more than doubled in size to increase capacities for clinical trial import and release activities

-...

Roche Austria: Susanne Erkens-Reck ist neuer General Manager

Mit der Besetzung des General Manager setzt Roche Austria ein weiteres Signal, dass es dem Unternehmen ernst ist mit...

Valneva Expands its Commercial Operations with the Opening of its French Commercial Office

Valneva SE (“Valneva” or “the Company”) today announced a further expansion of its global commercial infrastructure with...

Sanofi und WKÖ präsentierten das 11. Jahrbuch für Gesundheitspolitik und Gesundheitswirtschaft

ExpertInnen diskutierten auf hochrangig besetzter Veranstaltung Trends, Perspektiven und Herausforderungen für die...

Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate

Valneva SE (“Valneva” or “the Company”) announced today that an End Of Phase 2 (EOP2) meeting has been scheduled with...

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on then-current expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? Just send your contributions to news(at)lisavienna.at.